Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study

BACKGROUND: There is heterogeneity in the clinical manifestations and responses to drugs in RA patients due to variety of factors such as genes and environment. Despite advances in the treatment of rheumatoid arthritis (RA), approximately 40% of RA patients still do not achieve primary clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Rong, Li, Chun, Li, Xiaomei, Ke, Yao, Zhao, Ling, Chen, Lin, Wu, Rui, Wu, Zhenbiao, Zuo, Xiaoxia, Xie, Yanli, Chen, Jinwei, Wei, Wei, Liu, Yi, Li, Zhijun, Dai, Lie, Sun, Lingyun, Liu, Xiangyuan, Li, Zhanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315426/
https://www.ncbi.nlm.nih.gov/pubmed/34327344
http://dx.doi.org/10.1016/j.lanwpc.2021.100128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315426/
https://www.ncbi.nlm.nih.gov/pubmed/34327344
http://dx.doi.org/10.1016/j.lanwpc.2021.100128

Ejemplares similares